Ashley Cordova, Chief Executive Officer at NovoCure Ltd (NVCR), sold 2,053 shares at $18.54 ($38K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Seasonal sale ($38k) by Chief Executive Officer — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVCR | SELL | 2024-08-05 | $14K | — | Filing → |
| NVCR | SELL | 2023-09-05 | $19K | — | Filing → |
| NVCR | SELL | 2023-08-04 | $35K | — | Filing → |